Zimmer Biomet Holdings Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Zimmer Biomet Holdings Inc in the second quarter 2026?
Zimmer Biomet Holdings Inc achieved a return on average equity (ROE) of 6.36 % in its second quarter 2026, which is below Zimmer Biomet Holdings Inc 's average return on equity, which stands at 6.39%.

While the company's net income was fading, Zimmer Biomet Holdings Inc was able to improve its ROE compared to the first quarter 2026.

Within the Medical Equipment & Supplies industry 48 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 1870 to 1888.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	0.78 %	2.24 %	1.84 %	3.09 %	-
Y / Y Net Income Change	30.12 %	30.5 %	-42.52 %	-7.26 %	-36.9 %
Net Income (TTM) in Millions	807	761	705	807	825
Return On Equity (TTM)	6.36 %	6 %	5.6 %	6.44 %	6.63 %
ZBH's Total Ranking	# 1888	# 1870	# 1662	# 1667	# 1413
Equity (TTM) in Millions	12,633	12,682	12,706	12,766	12,534
Seq. Equity Change	-0.39 %	-0.19 %	-0.47 %	1.85 %	1.05 %
Seq. Net Income Change	-16.24 %	72.68 %	-40.31 %	50.72 %	-15.99 %

Back to ZBH Management Effectiveness >> ZBH's 5 Years Annual ROE >> Compare ZBH ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 49
Sector	# 162
Overall	# 1888

Return On Equity Statistics
High	Average	Low
17.11 %	6.39 %	-3.19 %
(Dec 31 2017)		(Dec 31 2018)

ZBH Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	12,706	12,476	12,488	12,027	12,666
Y / Y Equity Change	1.84 %	-0.1 %	3.83 %	-5.05 %	3.83 %
Net Income in Millions	705	905	1,025	232	402
Y / Y Net Income Change	-22.1 %	-11.69 %	341.09 %	-42.2 %	-
Return On Equity	5.55 %	7.26 %	8.21 %	1.93 %	3.17 %

Back to ZBH Management Effectiveness >> ZBH's 5 Years Annual ROE >> Compare ZBH ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 5.55 %, due to deterioration of net income.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ZBH's' Return on Equity at Yahoo Finance
ZBH's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ZBH's Competitors
Subscribers only: Roe for Zimmer Biomet Holdings Inc 's Suppliers
Subscribers only: Return On Equity for ZBH's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
Medinotec Inc	17.47 %
Lemaitre Vascular Inc	16.93 %
Ufp Technologies Inc	16.72 %
Ensign Group Inc	16.53 %
Stryker Corp	16.36 %
Nephros Inc	16.20 %
Spero Therapeutics Inc	16.17 %
Progyny Inc	15.98 %
Collegium Pharmaceutical Inc	15.96 %
Alpha Pro Tech Ltd	15.43 %
Livanova Plc	15.41 %
Biolife Solutions Inc	15.28 %
Lifevantage Corp	15.06 %
Quest Diagnostics Inc	14.85 %
Infusystem Holdings Inc	14.81 %
Boston Scientific Corporation	14.77 %
Strata Critical Medical Inc	14.27 %
Beone Medicines Ltd	14.24 %
Royalty Pharma Plc	13.82 %
Regeneron Pharmaceuticals Inc	13.81 %
National Healthcare Corp	13.11 %
Kewaunee Scientific Corporation	12.61 %
Protagonist Therapeutics inc	11.80 %
Entrada Therapeutics Inc	11.77 %
Haemonetics Corporation	11.66 %
Globus Medical Inc	11.59 %
Labcorp Holdings Inc	11.58 %
Tactile Systems Technology Inc	11.49 %
Nature s Sunshine Products inc	11.26 %
Penumbra Inc	11.09 %

Date modified: 2026-09-11T09:47:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.